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In this issue ofDevelopmental Cell, Elewa et al. (2015) show that combinatorial action of RNAbinding proteins
modulates poly(A) tail length of maternal mRNAs, leading to asymmetric expression of a cell fate determinant
in early C. elegans embryos. Genome-wide profiling suggests this mechanism may be widely used to estab-
lish cell identities.Although transcriptional gene regulatory
networks direct cell identity and differenti-
ation in embryos (Davidson and Erwin,
2006), the rapid early development of
many animals often necessitates a more
rapid mode of regulation of gene expres-
sion. This demand is met by systems
that mediate spatiotemporal differences
in expression of previously transcribed
mRNAs through the action of regulatory
RNA binding proteins (RBPs) (Ivshina
et al., 2014). Such mechanisms include
modulation of cytoplasmic polyadenyla-
tion (reviewed in Weill et al., 2012):
mRNAs with longer poly(A) tails generally
show increased stability and translat-
ability. In this issue of Developmental
Cell, Elewa et al. (2015) report that local-
ized RBPs combinatorially modulate
expression of a key cell fate regulator,
NEG-1, through cytoplasmic polyadeny-
lation of its mRNA. Moreover, poly(A) tail
lengths of many other messages are
controlled by factors that influence
neg-1 polyadenylation, raising the ex-
citing possibility that combinatorial inhibi-
tion and activation of cytoplasmic polya-
denylation by RBPs may represent a
major mode for establishing differences
in gene expression and cell identity in
early embryos.
Asymmetric division of the C. elegans
zygote provides a paradigm for illumi-
nating mechanisms by which maternal
factors establish differences in cell fate
(Go¨nczy and Rose, 2005). The larger ante-
rior, AB, and smaller posterior, P1, blasto-
meres possess distinct developmental
potentials: AB produces most of the
ectoderm, whereas P1 produces endo-
mesoderm, including the gut. This AB/P1
asymmetry is generated by the evolution-arily conserved PAR machinery. Subse-
quently, directed transport and spatially
specific degradation of maternal factors,
as well as localized translation of maternal
RNAs, result in unequal distribution of cell
fate determinants, including the endome-
soderm-activating bZIP transcription fac-
tor SKN-1, which is expressed at high
levels in the early P1 lineage. Much of
the control of cell type differences in the
early embryo occurs post-transcription-
ally. Indeed, many mediators that specify
cell identity in the AB and P1 lineages
are RBPs, several of which (e.g., POS-1
and MEX-5/6) contain CCCH-type Zn
fingers.
POS-1, like SKN-1, is required for en-
domesoderm development, but not for
SKN-1 expression, suggesting that it
activates the endomesoderm program
through another mechanism. Indeed, in
an RNAi screen for pos-1(-) suppressors,
Elewa et al. (2015) discovered that
POS-1 promotes endomesoderm devel-
opment by blocking, in P1, expression of
a novel protein, NEG-1 (Negative Effect
on Gut differentiation), which represses
the endomesoderm program in the AB
lineage. Loss of POS-1 results in the
absence of gut owing to failure to acti-
vate med-1/2, SKN-1 targets required
for endomesoderm development (Maduro
et al., 2001). neg-1 mutations restore
med-1/2 expression and hence gut devel-
opment in the absence of POS-1. Elimina-
tion of NEG-1 function also results in
ectopic expression of endomesoderm
markers in AB descendants at the ex-
pense of ectoderm, explaining the mor-
phogenetic defects of neg-1 mutant
embryos reported in another study (Os-
borne Nishimura et al., 2015).DevelopmentalWhile region-specific expression of
maternal regulatory proteins often results
from localized maternal transcripts, this
is largely not the case for C. elegans em-
bryos: transcripts of maternal regulators
(with exception of mex-3 and pos-1) are
generally uniformly distributed. However,
in a genome-wide study that profiled dif-
ferences in transcript abundancebetween
ABandP1,OsborneNishimura et al. (2015)
identified 281 asymmetrically distributed
transcripts. neg-1 RNA was among the
80 enriched transcripts in the AB lineage.
Because zygotic gene expression likely
initiates after the two-cell state, control
of AB/P1 asymmetry of neg-1 expression
is likely to occur post-transcriptionally.
Indeed, Elewa et al. found that neg-1 is
post-transcriptionally regulated by two
other proteins identified in their screen:
the non-canonical poly(A) polymerase
GLD-2 and its binding partner GLD-3, a
KH-domain RBP that recruits GLD-2, re-
sulting in cytoplasmic extension of poly(A)
tails. In wild-type embryos, neg-1 tran-
scripts (shown by Osborne Nishimura
et al., 2015) and NEG-1::GFP are ex-
pressed at high levels in the early AB
lineage, while in pos-1(-) mutants this
asymmetry is abolished and NEG-1::
GFP appears in the daughters of both
AB and P1. In contrast, NEG-1::GFP
expression is eliminated in the absence
of GLD-2 and -3, suggesting a role for
polyadenylation in regulation of NEG-1
expression (Elewa et al., 2015). Thus,
expression of NEG-1 is positively regu-
lated by GLD-2/3 and negatively regu-
lated by POS-1, likely through reciprocal
regulation of neg-1 mRNA stability.
The authors found that the neg-1 30UTR
contains three predicted, overlappingCell 34, July 6, 2015 ª2015 Elsevier Inc. 1
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Figure 1. Regulation of neg-1 by Differential Polyadenylation
Differential expression of NEG-1 depends on the combinatorial action of RNA
binding proteins, which regulate recruitment of the GLD-2 poly(A) polymerase.
(A) Schematic of neg-1 30UTR. (B) Relative amounts of MEX-5/6 and MEX-3
versus POS-1 determine whether the poly(A) tail of neg-1 mRNA is extended,
resulting in AB/P1 asymmetric expression. EMS, endomesoderm progenitor.
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for POS-1 and for MEX-5/6
and MEX-3, other RBPs
known to act as embryonic
fate determinants (Figure 1).
In vitro studies revealed that
MEX-5 outcompetes POS-1
for binding neg-1 RNA. Fur-
thermore, loss of MEX-5/6
from embryos was asso-
ciated with shorter poly(A)
tails on neg-1 transcripts,
whereas loss of POS-1 re-
sulted in longer tails, suggest-
ing that competition between
these RBPs determines neg-1
poly(A) tail length.
These results lead to the
following model (Figure 1). In
anterior blastomeres, high
MEX-5/6 andMEX-3 concen-trations relative to POS-1 allow recruit-
ment of GLD-2, which extends the neg-1
poly(A) tail, thereby promoting NEG-1
expression. In posterior blastomeres,
higher POS-1 levels lead to its occupancy
of the 30UTR, which precludes GLD-3-
mediated recruitment of GLD-2. The
resulting shorter poly(A) tails prevent
neg-1mRNA stabilization and translation,
thereby allowing expression of posterior
endomesodermal genes.
Interestingly, genome-wide profiling of
poly(A) tail lengths identified a large num-
ber of POS-1-repressed, GLD-2/3-acti-
vated mRNAs, suggesting that regulation
of neg-1 expression by differential polya-
denylation may represent the tip of a reg-
ulatory iceberg. In addition, many mRNAs
were identified whose poly(A) lengths
depend only on GLD-2 and not GLD-3,
raising the possibility that other RBPs
might recruit the GLD-2 poly(A) polymer-
ase to their respective target mRNAs.
Regulation of gene expression through
activation or repression of cytoplasmic
polyadenylation represents a novel mech-
anism for establishing differences in cell
identity in early embryos before transcrip-
tion has begun. Combinatorial regulation2 Developmental Cell 34, July 6, 2015 ª2015by RBPs has also been observed in other
contexts. For example, the sequential
binding of five RBPs restricts translation
of the Wnt-type ligand, MOM-2 (Olden-
broek et al., 2013), to particular blasto-
meres in the early embryo. The 30UTR of
many mRNAs may contain multiple bind-
ing sites for both positive and negative
regulators, the outcome being deter-
mined by the combination of their
respective abundance and binding affin-
ities of the RBPs. A recent bioinformatics
study predicted that as many as 887
(4.4% of all) C. elegans genes may
encode RBPs, of which 250 likely function
in a gene-specific manner (Tamburino
et al., 2013), providing a wealth of poten-
tial regulatory interactions. Thus, the
earliest events in embryogenesis might
well involve a combinatorial network of
RBPs, including the multiplicity of CCCH
Zn finger proteins, acting on target
mRNA binding sites.
It will be of great interest to learn how
widely such combinatorial control sys-
tems are used to generate cell type
diversity in metazoans (Ivshina et al.,
2014). Maturation of Xenopus oocytes
triggered by progesterone is accompa-Elsevier Inc.nied by elongation of poly(A)
tails of mRNAs by the
cytoplasmic polyadenylation
element binding (CPEB1) pro-
tein and an ortholog of the
C. elegans GLD-2 poly(A) po-
lymerase. In Drosophila, the
CPEB proteins Orb1 and
Orb2 activate translation of
Oskar mRNA at the posterior
of the oocyte by recruiting
poly(A) polymerase. Post-
transcriptional control of
mRNA by regulation of poly(A)
tail length is also evident
in gametogenesis, synaptic
plasticity, and immune re-
sponse associated with acute
inflammation (Weill et al.,
2012). Thus, modulation of
poly(A) tail length may be ageneral mechanism used widely across
metazoans when rapid post-transcrip-
tional deployment of gene expression
programs is required.
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